InsidersTradesSigma
Track the Embla Medical hf stock price and the full directors' dealings record of the company, a publicly traded company based in Denmark. Shares trade on the DK market, under the oversight of Finanstilsynet DK. Operating in the Health Care sector, Embla Medical hf has published 6 reports. Market capitalisation: €11.4bn. The latest transaction was reported on 28 May 2018 (Other). The full history is free.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Embla Medical hf Buy (bullish), based on 5 analysts. Average price target: DKK 33.50.
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,987 of 29,063 companies
51.2
score / 100
Value40
Quality62
FCF yld0.9%
Earn yld0.7%
EV/EBITDA·
ROE11%
Gross mgn62%
Net mgn9.0%
Debt/EBITDA2.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 May 2018
Acerca de Embla Medical hf
Embla Medical hf es una empresa centrada en el sector de la salud y farmacéutico, que ofrece soluciones innovadoras para el diagnóstico y tratamiento de trastornos del sueño. Cotiza en la bolsa XCSE.